Back to search

Article

A Lactylation-Related Radiosensitivity Index Predicts Differential Radiotherapy Benefit in Head and Neck Squamous Cell Carcinoma

2026-04-21

Abstract excerpt

<title>Abstract</title> <p>Radiotherapy (RT) is integral to the management of head and neck squamous cell carcinoma (HNSCC), yet no validated biomarker exists to predict which patients benefit most. Lactylation, a metabolic post-translational modification, has been linked to DNA damage repair (DDR) and therapeutic resistance, but no lactylation-based radiosensitivity biomarker has been established in HNSCC. Here,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
80882dbe-86a4-52c8-af51-3598bbb2d43e
DOI
10.21203/rs.3.rs-9250884/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Lactylation-Related Radiosensitivity Index Predicts Differential Radiotherapy Benefit in Head and Neck Squamous Cell CarcinomaDOI 10.21203/rs.3.rs-9250884/v1
Select a neighboring publication to make it the new centre.